PRME Prime Medicine, Inc.
Nasdaq · SEC CIK 1894562 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 102 since 2022-10-21, latest 2026-06-08 16:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 28
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-08-01 | 2025-08-01 | PRME | ARCH Venture Fund XII, L.P. | 10% | P - Purchase | $3.30 | +3.03M | 6.23M | +95% | +$10.00M |
| I | 2025-08-01 | 2025-08-01 | PRME | GILLIS STEVEN | 10% | P - Purchase | $3.30 | +3.03M | 6.23M | +95% | +$10.00M |
| I | 2025-08-01 | 2025-08-01 | PRME | NELSEN ROBERT | Dir, 10% | P - Purchase | $3.30 | +3.03M | 6.23M | +95% | +$10.00M |
| 2025-07-01 | 2025-06-30 | PRME | Liu David R. | 10% | P - Purchase | $2.52 | +21.0K | 20.24M | +0.1% | +$52.9K | |
| 2025-06-23 | 2025-06-23 | PRME | Liu David R. | 10% | P - Purchase | $2.16 | +21.0K | 20.22M | +0.1% | +$45.4K | |
| 2025-06-16 | 2025-06-16 | PRME | Liu David R. | 10% | P - Purchase | $1.49 | +21.0K | 20.20M | +0.1% | +$31.3K | |
| 2025-06-12 | 2025-06-11 | PRME | Liu David R. | 10% | P - Purchase | $1.60 | +21.0K | 20.18M | +0.1% | +$33.6K | |
| 2025-05-22 | 2025-05-21 | PRME | Reine Allan | CEO, Dir | P - Purchase | $1.18 | +125.0K | 125.0K | New | +$147.5K | |
| 2025-05-22 | 2025-05-20 | PRME | Brudnick Richard | Chief Business Off | P - Purchase | $1.19 | +20.0K | 20.0K | New | +$23.8K | |
| 2025-05-22 | 2025-05-21 | PRME | LEE ANN L. | Chief Technical Off | P - Purchase | $1.13 | +100.0K | 100.0K | New | +$113.0K | |
| MI | 2024-10-10 | 2024-10-08 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | 0 | 682.3K | New | $0 |
| I | 2024-06-07 | 2024-06-05 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | +250.0K | 277.2K | +920% | $0 |
| 2024-06-07 | 2024-06-05 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | -250.0K | 2.31M | -10% | $0 | |
| I | 2024-02-20 | 2024-02-15 | PRME | ARCH Venture Partners X, L.P. | 10% | P - Purchase | $6.25 | +3.20M | 3.20M | New | +$20.00M |
| I | 2024-02-20 | 2024-02-15 | PRME | NELSEN ROBERT | Dir, 10% | P - Purchase | $6.25 | +3.20M | 3.20M | New | +$20.00M |
| I | 2024-02-20 | 2024-02-15 | PRME | ARCH Venture Partners XII, LLC | 10% | P - Purchase | $6.25 | +3.20M | 3.20M | New | +$20.00M |
| 2023-11-14 | 2023-11-11 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | -7,500 | 2.56M | -0.3% | $0 | |
| I | 2023-11-14 | 2023-11-11 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | -5,000 | 27.2K | -16% | $0 |
| A | 2023-07-26 | 2023-07-21 | PRME | Liu David R. | 10% | G - Gift | $0.00 | -1.00M | 20.16M | -5% | $0 |
| 2023-07-25 | 2023-07-21 | PRME | Liu David R. | 10% | G - Gift | $0.00 | -1.00M | 20.16M | -5% | $0 | |
| D | 2022-10-26 | 2022-10-24 | PRME | Liu David R. | 10% | C - Cnv Deriv | — | +321.7K | 21.16M | +2% | — |
| DMI | 2022-10-26 | 2022-10-24 | PRME | ARCH Venture Partners X, LLC | 10% | P - Purchase | $17.00 | +800.0K | 6.13M | +15% | +$13.60M |
| DMI | 2022-10-26 | 2022-10-24 | PRME | ARCH Venture Partners X, LLC | 10% | C - Cnv Deriv | — | +11.46M | 5.73M | New | — |
| DI | 2022-10-26 | 2022-10-24 | PRME | Cahill Thomas | Dir | C - Cnv Deriv | — | +4.91M | 4.91M | New | — |
| DI | 2022-10-26 | 2022-10-24 | PRME | Cahill Thomas | Dir | P - Purchase | $17.00 | +400.0K | 5.31M | +8% | +$6.80M |
| DMI | 2022-10-26 | 2022-10-24 | PRME | NELSEN ROBERT | Dir, 10% | C - Cnv Deriv | — | +11.47M | 16.1K | New | — |
| DMI | 2022-10-26 | 2022-10-24 | PRME | NELSEN ROBERT | Dir, 10% | P - Purchase | $17.00 | +800.0K | 6.13M | +15% | +$13.60M |
| DMI | 2022-10-26 | 2022-10-24 | PRME | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +8.46M | 99.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations